About
Director at Avoro Capital since 2019, evaluating mid-to-late stage biotech investments. He earned an MD/PhD from Harvard Medical School and did residency in Clinical Pathology; his PhD focused on CRISPR-based gene therapy for sickle cell disease.
Contact· self-published, not guessed
Experience
- Vesta Ventures (We are hiring)Co-Founder
Colleagues at Avoro Capital Advisors
Andy Washkowitz
Director at Avoro Capital Advisors
Behzad Aghazadeh
Managing Partner and Portfolio Manager at Avoro Capital Advisors
Billy Smith
Associate at Avoro Capital Advisors
Bryan Phillips
Deputy Chief Compliance Officer at Avoro Capital Advisors
Corie Hansen
Office Manager / Executive Assistant at Avoro Capital Advisors
David Xiang
Associate at Avoro Capital Advisors
Diane Chien
Hedge Fund Controller at Avoro Capital Advisors
Jenna Glatzer
Associate - Avoro Ventures at Avoro Capital Advisors
Frequently asked questions
- Who is Matthew Canver?
- Director at Avoro Capital since 2019, evaluating mid-to-late stage biotech investments. He earned an MD/PhD from Harvard Medical School and did residency in Clinical Pathology; his PhD focused on CRISPR-based gene therapy for sickle cell disease.
- Where does Matthew Canver work?
- Matthew Canver is Director at Avoro Capital Advisors.
